Introduction: Crewmembers on ultra long-range commercial fl ights have the opportunity for rest and sleep in onboard areas in which the barometric pressure is 75.3 kPa (565 mmHg) or higher, equivalent to a terrestrial altitude of 2438 m (8000 ft) or lower. Sleep at higher altitudes is known to be disturbed, resulting in postsleep neurobehavioral performance decrements. We investigated the effects of sleep at 2438 m on oxygen saturation, heart rate, sleep quantity, sleep quality, postsleep neurobehavioral performance, and mood. Methods: Twenty men, 30-56 yr of age, participated in a blinded cross-over investigation conducted in a hypobaric chamber to compare the effects of sleep at altitude (ALT, 2438 m) and ground level (GND, 305 m). Results: SpO 2 measured before sleep was signifi cantly lower at ALT than at GND, 90.7 6 2.0% (average 6 SD) and 96.2 6 2.0%, respectively. During sleep, SpO 2 decreased further to 86.1 6 2.0% at ALT, and 92.3% 6 2.0% at GND. The percent of time during which SpO 2 was below 90% was 44.4% (3.6 -86.9%) at ALT and 0.1% (0.0 -22.9%) at GND. Objective and subjective measurements of sleep quantity and quality did not differ significantly with altitude, nor did postsleep neurobehavioral performance or mood. Discussion: The absence of signifi cant changes in sleep and postsleep neurobehavioral performance associated with pronounced oxygen desaturation during sleep was unexpected. Further study is needed to determine if the same effects occur in women and to characterize the changes in respiratory physiology that occur during sleep at 2438 m in both sexes. Keywords: altitude , commercial airplane , hypoxia , respiratory disturbance , sleep quality , sleep quantity , polysomnography , Psychomotor Vigilance Test , Automated Neuropsychological Assessment Metrics .
T WO fl ight crews and two cabin crews are used on ultra long-range commercial airplane fl ights. While one is on duty, the other has the opportunity to sleep in onboard areas in which the barometric pressure can be as low as 75.3 kPa (565 mmHg), equivalent to a terrestrial altitude as high as 2438 m (8000 ft). In-fl ight studies of crewmembers conducted during ultra long-range fl ights have documented sleep disturbances which have been attributed to various causes such as noise, turbulence, temperature, humidity, inadequate bedding, or the presence of other individuals in the sleep area ( 15 , 16 ) .
Unacclimatized travelers to high terrestrial altitudes experience sleep-related respiratory disturbances, hypoxemia, impaired quantity and quality of sleep, and impaired postsleep performance ( 19 , 20 ) . The altitude and SpO 2 thresholds for the onset of altitude-related sleep disturbances, if thresholds exist, are not readily ascertained from the current literature. It is possible that the hypoxemia occurring during sleep at 2438 m also contributes to the sleep disturbances observed in fl ightcrew members.
We conducted a study in a hypobaric chamber to evaluate the effect of sleep in barometric pressures equivalent to altitudes of 2438 m and 305 m (1000 ft) on blood oxygenation and sleep quantity and quality. Because sleep disturbances, regardless of cause, adversely affect neurobehavioral performance and mood ( 18 ) , we also examined those outcomes. If adverse effects were found at the barometric pressure equivalent to 2438 m, our intention was to determine if sleep in the barometric equivalent of 305 m would ameliorate those effects. We therefore included a condition in which pre-and postsleep altitudes were 2438 m and the sleep altitude was 305 m.
METHODS
The protocol was approved in advance by the Institutional Review Boards of Oklahoma State Univer sity Center for Health Sciences and The Boeing Company. Each subject provided written informed consent after being informed of the study's purpose, procedures, time commitment, and risks and benefi ts of participation.
Male volunteers 30 -60 yr of age were recruited from the general population of Tulsa, OK [altitude 198 m (650 ft)]. Potential subjects were required to meet FAA Class III physical standards (except for vision and hearing requirements) that exclude signifi cant past or present cardiovascular, pulmonary, and sinus disease. Their body mass index was required to be 35 or less and their height 1.88 m (74 inches) or less. Subjects' race and ethnicity were not considered.
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All subjects completed a screening questionnaire investigating issues of general health, mood, and sleep, which included the Epworth Sleepiness Scale ( 9 ), the Pittsburgh Sleep Quality Index ( 3 ), the Horne and Ostberg Morning-Eveningness Scale ( 8 ) , and the 21-question Depression, Anxiety, and Stress Scales ( 10 ) . Those whose responses indicated the presence of a sleep disorder, excessive daytime sleepiness, poor quality sleep, or extreme circadian phase were excluded. In addition, individuals whose mood was assessed as possibly affecting sleep and those who reported using stimulants, including any nicotine or more than 3 caffeinated beverages per day (approximately 300 mg caffeine) were excluded.
Subjects were instructed to maintain stable sleep patterns during the week preceding each study session and to wear actiwatches (Mini Mitter, Bend, OR) and maintain sleep diaries to assess compliance. On the day of each study session, subjects were screened for acute disqualifying conditions: infectious disease, recent major surgical procedure, dental abscess, scuba diving within 24 h of the study, and drug or alcohol intoxication.
The study was conducted in a hypobaric chamber (C.G.S. Scientifi c Corporation) located in the Center for Aerospace and Hyperbaric Medicine at Oklahoma State University Center for Health Sciences in Tulsa, OK. The chamber, ventilated at no less than 10 cfm/occupant, was equipped with an airlock that allowed ingress and egress of personnel and supplies without affecting the barometric pressure in the main chamber. The barometric pressure used to simulate 305 m was 97.7 kPa (733 mmHg), and 75.3 kPa (565 mmHg) to simulate 2438 m. Temperature and relative humidity were measured once per minute during the 18 h of each study session. The main compartment of the chamber was fi tted with four beds in which the subjects slept. The beds were arranged against the walls of the chamber, end-to-end and two on a side with an aisle between. Opaque curtains were pulled between the beds during the sleep period for privacy. Each subject was given soft ear plugs and sleep masks to wear during the sleep period. Dinner was provided 4 h before the beginning of the sleep period, breakfast at the beginning of the postsleep period. Noncaffeinated beverages were available throughout the study session. A sink and toilet were located in the airlock.
The study used a prospective, double-blind, crossover design in which each subject was scheduled to participate in three 18-h study sessions starting at 1700, each consisting of a 6-h presleep period, a 7-h sleep period, and a 5-h postsleep period. The study sessions differed by the combinations of altitudes simulated in the three periods. In condition GND, all three periods were conducted at a simulated altitude of 305 m; in condition ALT, all periods at a simulated altitude of 2438 m; and in condition MIX the presleep and postsleep pressures were conducted at a simulated altitude of 2438 m and the intervening sleep period at 305 m. The study design called for the order of exposure to the study conditions to be balanced across study subjects to minimize possible order effects. Study sessions for individual subjects were separated by no less than 3 wk to allow for resolution of any possible altitude acclimatization occurring during the preceding study session. To maintain subject blinding to different barometric pressures, the barometric pressure was transiently changed to 87.5 kPa [656 mmHg (1219 m, 4000 ft)] at the beginning and end of the study session and at the beginning and end of the sleep period in condition GND, and at the beginning and end of the sleep period in condition ALT. To maintain blinding of the research staff while they entered or exited the chamber, the airlock was decompressed to 87.5 kPa (1219 m) before being recompressed in conditions GND and MIX. No formal assessment of the success of the blinding was made.
Measurements of blood oxygenation included oxygen saturation measured by pulse oximetry (SpO 2 ), desaturation index (the number of times per hour a sleeping individual's SpO 2 decreased Ն 4% below the preceding baseline for Ն 10 s), and percent of time in which SpO 2 was less than 90% during sleep. SpO 2 and heart rate (HR) were measured using fi ngertip probes and oximeters (Nonin PalmSat Model 2500). During both the preand postsleep periods SpO 2 and HR were recorded at a frequency of 0.25 Hz for approximately 2 min on three separate occasions at 1 h 45 min intervals. SpO 2 and HR were recorded continuously at a frequency of 0.25 Hz throughout the 7-h sleep period.
Electroencephalographic (EEG), extraocular (EOG), and electromyographic (EMG) recordings were obtained from each subject during the 7-h sleep period using an ambulatory recorder (A10, Embla) and the electrode montage: C4-A1, C3-A2, EOG R-A1, EOG L-A2, EMG. Signals were fi ltered (0.5 -90 Hz), stored on a data card, and downloaded at the end of the protocol. Sleep, awakenings, and arousals from sleep were scored according to the standard criteria ( 1 , 14 ) . All sleep recordings were viewed by two independent, experienced sleep scorers (interrater reliability . 90% for all recordings). A postsleep questionnaire developed by Massey University that contained nine questions assessing perception of sleep quantity and quality was administered at the beginning of the postsleep period.
Neurobehavioral performance was assessed using the Psychomotor Vigilance Test (PVT) ( 6 ) (PVT-192 Ambulatory Monitoring, Ardsley, NY), and the Simple Reaction, Two Choice Reaction Time, Tower of Hanoi, Switching, and Continuous Performance tests of the Automated Neuropsychological Assessment Metrics (ANAM) test battery that assess vigilance, memory, and executive functioning ( 2 ) . The Simple Reaction test was administered twice -once at the beginning and once at the end -during each ANAM test battery. Mood was assessed with the Profi le of Mood States (POMS) ( 11 ) . The PVT, ANAM battery, and POMS were administered at hours 1, 2, and 4 after the beginning of the pre-and postsleep periods.
Statistical Analysis: We estimated that 19 male subjects were suffi cient to provide 80% power to detect a 25 ms difference in PVT response times (corresponding to 0.71 SLEEP AT SIMULATED 2438 m -MUHM ET AL. standard deviations) or a 30-min difference in total sleep time (0.77 standard deviations) at the 0.05 confi dence level. Our target of 24 subjects allowed for a dropout rate of up to 20%. Mixed linear models were used to determine if altitude affected SpO 2 , heart rate, sleep quantity and quality, the postsleep minus presleep difference in neurobehavioral performance, and subjective assessments of mood and sleep (SAS for Windows v9.1). The independent variables in each model were: study condition (GND, ALT, MIX), order in which the condition was completed (1 st , 2 nd , 3 rd ), total sleep in the 24 h prior to the protocol (number of hours as measured by the actigraph), age (years), and the interaction of study condition and order. Because multiple trials of SpO 2 , heart rate, neurobehavioral performance, and mood were administered each session, the models of these outcomes also included trial number and the interaction of trial number and study condition as independent variables. Analyses of PVT data were conducted using both reaction time (RT) and speed (1/RT). For both measurements, the mean, median, standard deviation, 10 th percentile, 90 th percentile, and rate of change over the 10-min test session were analyzed. In addition, a Poisson regression model was used to analyze the number of lapses, defi ned as a reaction time greater than 500 ms. In this paper we primarily report the analysis of mean reaction time. The Wilcoxon signed-rank test was used to compare medians of nonparametrically distributed variables.
RESULTS
Eighty-fi ve males were screened for the study after giving informed consent, 58 of whom were excluded due to one or more of the exclusion criteria. Twentyseven were selected to participate, 3 of whom did not due to scheduling confl icts, resulting in 24 approved subjects. One removed himself for personal reasons and did not participate in any sessions. Data from 3 who participated were excluded: 1 who did not comply with the study protocol and participated in only 1 session, and 2 who had desaturation indices greater than 15 during sleep at 305 m, suggesting previously undetected respiratory disturbance, resulting in 20 subjects who completed a total of 57 subject-sessions (1 subject participating in 1 session is one subject-session). The polysomnographic recording during one subject-session could not be analyzed because of technical problems. Subjects' ages were (mean 6 std dev) 44. 1 
Data was collected between 10/17/06 and 2/17/07. The range of average temperatures in the chamber over the 20 study sessions was 18.1°C -23.7°C (64.6°F -74.6°F), and the range of average relative humidity was 22.7 -64.7%. The allocation of subjects to study condition was not completely balanced across order of exposure: 9 of 19 experienced condition ALT on the fi rst night; 10 of 19 experienced MIX on the second night; and 9 of 20 experienced GND on the third night.
Mixed model analysis showed average SpO 2 to be signifi cantly related to condition, trial number, and the interaction between condition and trial number ( Table I ) ( Fig. 2 ) . Visual inspection of SpO 2 data indicated that baseline SpO 2 remained relatively stable across the sleep period in the 2438-m condition after an initial drop following sleep onset.
Heart rate was not signifi cantly related to condition but was signifi cantly related to age, trial number, and the interaction of condition and trial number ( Table I ) . Heart rate decreased as age increased.
Measurements of sleep quantity (total sleep time and wake time), and sleep quality (sleep effi ciency, sleep latency, awakenings/hour, arousals/hour, and sleep architecture) were not signifi cantly related to condition. Some were signifi cantly related to order and age -in SLEEP AT SIMULATED 2438 m -MUHM ET AL.
general sleep was more disturbed during the fi rst study session than in subsequent sessions, and older subjects had more disturbed sleep ( Table II ) . The responses to one of the nine questions on the postsleep questionnaire were found to be related to condition with sleep reported as being of poorer quality at ALT than at GND. A " conservative " subset of the results was created for reanalysis of measurements of sleep quantity and quality by excluding all data from sessions in which the total time for analysis (time in bed) was outside 420 6 1 min. The analyses of sleep quantity and quality based on this subset support the reported analyses. Tests of neurobehavioral performance and mood were not signifi cantly related to condition ( Table III ) . Trial number had a signifi cant effect on PVT reaction time, with longer reaction times tending to occur in trials toward the end of the simulated fl ight compared with those at the beginning of the fl ight. Speed of PVT response was not signifi cantly related to condition. Run order had a signifi cant effect on some of the ANAM tests, and in all cases poorer performance tended to occur in the fi rst simulated fl ight compared with fl ights 2 and 3. Age had a signifi cant effect on performance on the Two Choice test, with older subjects tending to have longer reaction times. Trial number had a signifi cant effect on Tower of Hanoi, with shorter reaction times tending to occur in later trials. Trial number had a signifi cant effect on some POMS axes, with scores for Vigor lower and for Fatigue higher for the trials immediately prior to sleep, and those for tension and depression highest during the prefl ight trial. Age had a signifi cant effect on the score for Vigor, with the score increasing as age increased.
DISCUSSION
We found that sleep in barometric pressures equivalent to 2438 m was accompanied by moderately severe hypoxemia but not by adverse effects on sleep quantity, sleep quality, postsleep neurobehavioral performance, or mood in 30 -56 yr old healthy men. From studies at lower altitudes, we expected this level of hypoxemia to be consistent with sleep fragmentation and neurobehavioral performance impairment ( 12 , 18 ) .
The study had suffi cient statistical power to detect functionally important differences in total sleep time and neurobehavioral performance. The lower limit of the 95% confi dence interval for the difference in total sleep time between 2438 m and 305 m was -28 min, greater than the -30 min difference considered a priori to be functionally important. Similarly, the upper limit of the 95% confi dence interval for the difference in the neurobehavioral performance measure of primary interest, mean PVT response time between 2438 m and 305 m, was 2.2 ms, implying that the effect of sleep at an altitude of 2438 m was unlikely to be as high as 25 ms, the amount considered functionally important. Therefore we conclude that it is unlikely that an important effect SLEEP AT SIMULATED 2438 m -MUHM ET AL. on mean PVT response time or sleep quantity was missed due to small sample size ( 7 ).
Our failure to achieve a balanced participation by order and condition introduced two biases that tended to increase the apparent differences in measurements of sleep quantity and quality between 305 m and 2438 m. The purpose of balancing was to equalize the contribution of the deleterious " fi rst night " effects on sleep in unaccustomed surroundings across the three conditions. In our study, 47% of subjects experienced the 2438-m sleep period during their fi rst study session, when sleep disruption from adaptation to the recording equipment and the chamber environment was maximal, whereas 45% experienced the 305-m sleep period during their third study session, by which time the sleep disruption resulting from adaptation was minimal. A second bias was introduced by imprecise control of total sleep time which, on average, was shorter during the subjects' fi rst study run. Because of the unbalanced participation, this would have affected the 2438-m sleep period disproportionately, again tending to worsen average measurements of sleep at 2438 m. The small differences we observed in the measurements of sleep quantity, sleep quality, neurobehavioral performance, and mood between sleep at 2438 m and 305 m were probably larger than the true differences, suggesting that it is unlikely that important effects of sleep at altitude were missed due to these biases.
It is unlikely that we overestimated the desaturation index or percent of time SpO 2 Յ 90% because the relatively low sampling rate for SpO 2 (0.25 Hz) we used is likely to have caused us to underestimate the duration of desaturation events, and therefore underestimate the number of desaturation events and percent of sleep time Յ 90% ( 5 ). Variations in the timing and duration of the transient pressure changes introduced at the beginning and end of the sleep periods may explain the small apparent differences in the desaturation index and percent of time below 90% observed between conditions GND and MIX -conditions in which the assigned altitude during sleep was 305 m ( Figs. 1 and 2 ) . No measurements of respiratory physiology were made so the mechanisms underlying the hypoxic episodes cannot be known from this study. Thomas et al. found that altitude-induced respiratory abnormalities at 3962 m (13,000 ft) include both central and obstructive events ( 17 ) .
Sleep at 305 m in our study more closely resembled sleep in members of an aircrew at a layover hotel than normal sleep in 40 -49 yr old men. More time was spent in the lighter stages of sleep and there were more awakenings per hour than in normal sleep. On the other hand, sleep during rest periods in fl ight was shorter, lighter, and more disturbed than observed at 2438 m in our study, raising the possibilities that the effect of altitude was underestimated in our study, or that factors other than altitude affect sleep during fl ight ( 16 ) . Thomas et al. found that sleep at 3962 m was not associated with decrements in working memory or simple reaction time in healthy nonsmoking men and women with a mean age of 27 yr and a mean BMI of 23 ( 17 ) . SLEEP AT SIMULATED 2438 m -MUHM ET AL.
Their fi ndings together with ours suggest that the magnitude of hypoxemia observed during sleep in healthy people at 2438 -3962 m is insuffi cient by itself to produce neurobehavioral performance decrements. It is unknown if this can be generalized to those with illnesses that affect oxygen delivery. The changes in oxygen saturation found in our study suggest that respiration during sleep is disturbed at 2438 m, but the lack of concomitant sleep disturbances makes the functional signifi cance of this fi nding for fl ight crew unclear. Our results indicate that when altitude ex posure is acute (1 night only), neurobehavioral performance and sleep are not signifi cantly affected. Nevertheless, respiratory disturbances during sleep at 2438 m and associated hypoxemia may adversely affect cardiovascular health if suffi ciently severe and prolonged ( 4 , 13 ) . Given that ultra long-range fl ight crew members may sleep at altitude several times a week during a 30-40 yr career, these fi ndings merit further investigation. In particular, more information is needed concerning the physiologic mechanisms underlying the respiratory disturbances, the consequences of the resulting changes in pulmonary ventilation, and the altitude threshold at which respiratory disturbances and sleep changes occur.
In summary, we found a pronounced degree of oxygen desaturation during sleep at 2438 m, but no significant differences in objective measurements of sleep quantity, sleep quality, postsleep neurobehavioral performance, nor subjective measurements of mood and sleep quality in 30 -56 yr-old healthy men. Further study is needed to determine if the same effects occur in women and to characterize the changes in respiratory physiology that occur during sleep at 2438 m altitude in both men and women. 
